Steffen M. Heckl

Kiel, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

MYC amplification is common in cancer of the stomach and gastroesophageal junction, correlates with male sex and reduced response to neoadjuvant therapy.

MYC amplification is common in cancer of the stomach and gastroesophageal junction, correlates with male sex and reduced response to neoadjuvant therapy.

Journal: BMC cancer

Published: December 14, 2025

MET-amplified gastric cancers exhibit co-amplifications of BRAF, CDK6, and EGFR.

MET-amplified gastric cancers exhibit co-amplifications of BRAF, CDK6, and EGFR.

Journal: The journal of pathology. Clinical research

Published: December 14, 2025

The Potential of Artificial Intelligence to Improve Selection Criteria for Liver Transplantation in HCC.

The Potential of Artificial Intelligence to Improve Selection Criteria for Liver Transplantation in HCC.

Journal: Cancers

Published: October 11, 2025

Impact of Becoming a Certified Oncologic Center of Pancreatic Surgery: Evaluation of Single-Center Perioperative Results and Quality of Life Before and After Implementation of a Certified Center.

Impact of Becoming a Certified Oncologic Center of Pancreatic Surgery: Evaluation of Single-Center Perioperative Results and Quality of Life Before and After Implementation of a Certified Center.

Journal: Diseases (Basel, Switzerland)

Published: September 21, 2025

Impact of adjuvant therapy on outcomes of cancer of the stomach and gastroesophageal junction in the real-world.

Impact of adjuvant therapy on outcomes of cancer of the stomach and gastroesophageal junction in the real-world.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: February 10, 2025

Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpression.

Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpression.

Journal: Scientific reports

Published: September 05, 2024

LAG3 in gastric cancer: it's complicated.

LAG3 in gastric cancer: it's complicated.

Journal: Journal of cancer research and clinical oncology

Published: April 10, 2023

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma.

Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma.

Journal: Frontiers in oncology

Published: February 07, 2023

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.

Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.

Journal: Frontiers in immunology

Published: February 02, 2023

SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co-amplification.

SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co-amplification.

Journal: Cancer medicine

Published: November 01, 2022

Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer.

Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer.

Journal: Journal of personalized medicine

Published: September 29, 2021

Insulin Receptor in Pancreatic Cancer-Crown Witness in Cross Examination.

Insulin Receptor in Pancreatic Cancer-Crown Witness in Cross Examination.

Journal: Cancers

Published: August 22, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026